M. Visalli

发表

Susceptibilities of Penicillin- and Erythromycin-Susceptible and -Resistant Pneumococci to HMR 3647 (RU 66647), a New Ketolide, Compared with Susceptibilities to 17 Other Agents

M. Jacobs, P. Appelbaum, G. Pankuch, 1998, Antimicrobial Agents and Chemotherapy.

Antipneumococcal activity of BAY 12-8039, a new quinolone, compared with activities of three other quinolones and four oral beta-lactams

M. Jacobs, P. Appelbaum, M. Visalli, 1997, Antimicrobial agents and chemotherapy.

Susceptibility of penicillin-susceptible and -resistant pneumococci to dirithromycin compared with susceptibilities to erythromycin, azithromycin, clarithromycin, roxithromycin, and clindamycin

M. Jacobs, P. Appelbaum, M. R. Jacobs, 1997, Antimicrobial agents and chemotherapy.

Susceptibility of twenty penicillin-susceptible and -resistant pneumococci to levofloxacin, ciprofloxacin, ofloxacin, erythromycin, azithromycin, and clarithromycin by MIC and time-kill.

M. Jacobs, P. Appelbaum, M. Visalli, 1997, Diagnostic microbiology and infectious disease.

Antipneumococcal activities of cefpirome and cefotaxime, alone and in combination with vancomycin and teicoplanin, determined by checkerboard and time-kill methods

M. Jacobs, S. Bajaksouzian, P. Appelbaum, 1996, Antimicrobial agents and chemotherapy.

Activity of CP 99,219 (trovafloxacin) compared with ciprofloxacin, sparfloxacin, clinafloxacin, lomefloxacin and cefuroxime against ten penicillin-susceptible and penicillin-resistant pneumococci by time-kill methodology.

M. Jacobs, P. Appelbaum, M. Visalli, 1996, The Journal of antimicrobial chemotherapy.

Comparative activities of clarithromycin, erythromycin, and azithromycin against penicillin-susceptible and penicillin-resistant pneumococci

M. Jacobs, L. Ednie, P. Appelbaum, 1996, Antimicrobial agents and chemotherapy.

MIC and time-kill study of activities of DU-6859a, ciprofloxacin, levofloxacin, sparfloxacin, cefotaxime, imipenem, and vancomycin against nine penicillin-susceptible and -resistant pneumococci

M. Jacobs, P. Appelbaum, M. Visalli, 1996, Antimicrobial agents and chemotherapy.

Comparative activity of trovafloxacin, alone and in combination with other agents, against gram-negative nonfermentative rods

M. Jacobs, S. Bajaksouzian, P. Appelbaum, 1997, Antimicrobial agents and chemotherapy.

Activities of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with amikacin, against acinetobacters as determined by checkerboard and time-kill studies

M. Jacobs, S. Bajaksouzian, M. R. Jacobs, 1997, Antimicrobial agents and chemotherapy.

Susceptibilities of non-Pseudomonas aeruginosa gram-negative nonfermentative rods to ciprofloxacin, ofloxacin, levofloxacin, D-ofloxacin, sparfloxacin, ceftazidime, piperacillin, piperacillin-tazobactam, trimethoprim-sulfamethoxazole, and imipenem

M. Jacobs, P. Appelbaum, M. R. Jacobs, 1996, Antimicrobial agents and chemotherapy.

Efflux-Mediated Resistance to Tigecycline (GAR-936) in Pseudomonas aeruginosa PAO1

C. Dean, P. Bradford, S. Projan, 2003, Antimicrobial Agents and Chemotherapy.

AcrAB Multidrug Efflux Pump Is Associated with Reduced Levels of Susceptibility to Tigecycline (GAR-936) in Proteus mirabilis

P. Bradford, S. Projan, E. Murphy, 2003, Antimicrobial Agents and Chemotherapy.

Molecular epidemiology of a citywide outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae infection.

P. Bradford, D. Landman, J. Quale, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Activities of oral and parenteral agents against penicillin-susceptible and -resistant pneumococci

M. Jacobs, P. Appelbaum, G. Pankuch, 1995, Antimicrobial agents and chemotherapy.

Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 beta-lactamases in New York City.

P. Bradford, D. Landman, J. Quale, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Influence of Transcriptional Activator RamA on Expression of Multidrug Efflux Pump AcrAB and Tigecycline Susceptibility in Klebsiella pneumoniae

P. Bradford, D. Keeney, A. Ruzin, 2005, Antimicrobial Agents and Chemotherapy.

Pyrosequencing Using the Single-Nucleotide Polymorphism Protocol for Rapid Determination of TEM- and SHV-Type Extended-Spectrum β-Lactamases in Clinical Isolates and Identification of the Novel β-Lactamase Genes blaSHV-48, blaSHV-105, and blaTEM-155

P. Bradford, P. Petersen, A. Ruzin, 2008, Antimicrobial Agents and Chemotherapy.

Activities of Three Quinolones, Alone and in Combination with Extended-Spectrum Cephalosporins or Gentamicin, against Stenotrophomonas maltophilia

M. R. Jacobs, P. Appelbaum, M. Visalli, 1998, Antimicrobial Agents and Chemotherapy.

Determining incidence of extended spectrum beta-lactamase producing Enterobacteriaceae, vancomycin-resistant Enterococcus faecium and methicillin-resistant Staphylococcus aureus in 38 centres from 17 countries: the PEARLS study 2001-2002.

P. Bradford, D. Hoban, S. Bouchillon, 2004, International journal of antimicrobial agents.

The Varicella-zoster virus DNA encapsidation genes: Identification and characterization of the putative terminase subunits.

M. Visalli, R. Visalli, D. M. Nicolosi, 2007, Virus research.

Activities and Time-Kill Studies of Selected Penicillins, β-Lactamase Inhibitor Combinations, and Glycopeptides against Enterococcus faecalis

M. R. Jacobs, P. Appelbaum, D. Hoellman, 1998, Antimicrobial Agents and Chemotherapy.

Determination of Activities of Levofloxacin, Alone and Combined with Gentamicin, Ceftazidime, Cefpirome, and Meropenem, against 124 Strains of Pseudomonas aeruginosa by Checkerboard and Time-Kill Methodology

M. R. Jacobs, P. Appelbaum, M. Visalli, 1998, Antimicrobial Agents and Chemotherapy.

The Varicella-Zoster Virus Portal Protein Is Essential for Cleavage and Packaging of Viral DNA

M. Visalli, Hua Zhu, Brittany L House, 2014, Journal of Virology.

In vivo antitumor activity of S 16020-2, a new olivacine derivative

E. Bisagni, L. Kraus-Berthier, M. Visalli, 1996, Cancer Chemotherapy and Pharmacology.

Identification of the Epstein Barr Virus portal.

M. Visalli, R. Visalli, A. Schwartz, 2019, Virology.

Intermolecular Complementation between Two Varicella-Zoster Virus pORF30 Terminase Domains Essential for DNA Encapsidation

M. Visalli, Brittany L House, R. Visalli, 2015, Journal of Virology.

The Varicella-zoster virus ORF54 gene product encodes the capsid portal protein, pORF54.

D. Sherman, Denise M. Burnside, M. Visalli, 2012, Virus research.

The Varicella-Zoster Virus ORF 54 Gene Product Encodes the Capsid Portal Protein , pORF 54

D. Sherman, Denise M. Burnside, M. Visalli, 2012 .

Characterization of the Varicella-zoster virus ORF25 gene product: pORF25 interacts with multiple DNA encapsidation proteins.

Denise M. Burnside, M. Visalli, R. Visalli, 2009, Virus research.

Sequence, biochemical characterization, and developmental expression of a new member of the TGF-beta superfamily in Drosophila melanogaster.

F. Hoffmann, M. Visalli, P. D. Jackson, 1992, Developmental biology.

fau and its ubiquitin-like domain (FUBI) transforms human osteogenic sarcoma (HOS) cells to anchorage-independence

T. Rossman, E. Komissarova, M. Visalli, 2003, Oncogene.

Activities of beta-lactams against Acinetobacter genospecies as determined by agar dilution and E-test MIC methods

M. Jacobs, P. Appelbaum, M. R. Jacobs, 1997, Antimicrobial agents and chemotherapy.

In vivo immunopharmacological properties of tuftsin and four analogs.

M. Vincent, L. Kraus-Berthier, M. Visalli, 1993, Immunopharmacology.

Approaches to some biochemical mechanisms of action of tuftsin and analogues.

G. Ferry, J. Boutin, M. Vincent, 1991, Biochemical pharmacology.

Synergistic Activity of Trovafloxacin with Other Agents

M. Jacobs, S. Bajaksouzian, P. Appelbaum, 1999, Drugs.

Synergistic activity of trovafloxacin with other agents against gram-positive and -negative organisms.

M. Jacobs, S. Bajaksouzian, P. Appelbaum, 1998, Diagnostic microbiology and infectious disease.

Characterization of the murine cytomegalovirus m136 gene

M. Visalli, R. Visalli, D. M. Nicolosi, 2007, Virus Genes.